No Detail Found!

Efficacy of microneedling combined with calcipotriol plus betamethasone in the treatment of vitiligo

Author(s)
Saima Manzoor Dermatologist, Ultracare Hospital,Wapda Town, Gujranwala,Pakistan
Anum Sadia Department of Dermatology, Sir Ganga Ram Hospital,Lahore,Pakistan
Madiha Siddique Department of Dermatology, Social Security Hospital Gujranwala,,Pakistan
Ayesha Mumtaz Department of Dermatology, Khawaja Arshad Family Hospital,Sargodha,Pakistan
Nadia Ali Azfar Department of Dermatology, Allama Iqbal Medical College, Jinnah Hospital Lahore,,Pakistan
Rabia Hayat Department of Dermatology, Fatima Jinnah Medical University/ Sir Ganga Ram Hospital,Lahore,Pakistan
Abstract
Objective To assess the outcome of microneedling combined with calcipotriol plus betamethasone (measured by mean change in VASI) in the treatment of vitiligo. Methods This study involved 57 patients of both genders aged between 15-45 years presenting with vitiligo enrolled after taking informed written consents. These patients were assessed by VASI score before starting treatment. Treatment was given in the form of microneedling combined with calcipotriol plus betamethasone. VASI score was reassessed 2 weeks after 3 months of treatment. Outcome variable was mean change in VASI score which was measured by subtracting the followup VASI score from that at baseline and compared across various subgroups of studied patients. Results Mean age of the patients was 26.4±8.9 years. There were 26 (45.6%) male and 31 (54.4%) female patients. Mean duration of disease was 4.56±1.71 years. Family history of vitiligo was present in 16 (28.1%) patients. The mean change in VASI score from baseline was 39.65±4.97. Mean change in VASI score across various subgroups of patients had insignificant difference (pvalue>0.05). Conclusion Microneedling combined with calcipotriol and betamethasone was associated with considerable mean change in VASI score in vitiligo patients which owing to safety and simplicity of treatment advocates its preferred use in managing such patients in future dermatological practice.
Publication Details
Page(s) 25-30
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 34, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Betamethasone, Vitiligo, Microneedling, calcipotriol, VASI Score
References
Joge RR,Kathane PU,Joshi SH .2022 .Vitiligo: a narrative review. Cureus, 10(9) : .
Santosh SK,Sushantika I,Mohan L,Gupta AK,Mohammad A,Kumar N. .2018 .Treatment of Vitiligo with 5-fluorouracil after microneedling of the lesion. Int J Sci Stud, 5(11) : 125-7.
Husain MA,Alam MN,Rahim R,Joarder Y .2017 .Efficacy and safety of topical tacrolimus (0.03%) in the treatment of localized vitiligo. Med Today, 29(1) : 1-5.
Bilal A,Shiakh ZI,Khan S,Iftikhar N,Sadiq S. .2014 .Efficacy of 0.1% topical tacrolimus with narrow band ultraviolet B phototherapy versus narrow band ultraviolet B phototherapy in vitiligo. J Pak Assoc Dermatol, 24(4) : 327-31.
Zaib SR,Rashid S,Faraz AAK .2017 .To assess the efficacy of topical 0.03% tacrolimus ointment in the treatment of vitiligo. Pak J Med Health Sci, 11(2) : 616-9.
Chhabra S,Chahar YS,Singh A .2021 .A comparative study of microneedling combined with topical 5-fluorouracil versus microneedling alone in treatment of localized stable vitiligo. Indian J Dermatol, 66(5) : 574-80.
Zeid OM,Omar N,El Sharkawy D. .2020 .The efficacy of combining fractional CO2 laser and tacrolimus ointment in the treatment of vitiligo. J Egypt Women Dermatol Soc, 17(1) : 25-30.
Sardana K,Verma G .2018 .Overview of medical therapies and phototherapy in vitiligo based on their pathogenetic action and the role of platelet-rich plasma. J Cutan Aesthet Surg, 68 : 17-8.
Mumtaz H,Anis S,Akhtar A,Rubab M,Zafar A,Niazi N .2020 .Efficacy of tacrolimus versus clobetasol in the treatment of vitiligo. Cureus, 10(12) : .
Abd‐Elazim NE,Yassa HA,Mahran AM .2020 .Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo. J Cosmet Dermatol, 10(6) : 1447-55.
Zahoor M,Shaukat S,Khan MS,Ahmad TJ .2017 .Comparison of efficacy and safety of 0.005% calcipotriol ointment versus 0.05% betamethasone dipropionate ointment versus calcipotriol plus betamethasone ointment for the treatment of vitiligo. J Pak Assoc Dermatol, 27(1) : 30-6.
Alam MN,Wahab MA,Khondker L,Khan MSI .2014 .Comparative efficacy and safety of the combination of betamethasone dipropionate and calcipotriene with topical betamethasone dipropionate and calcipotriene alone in the treatment of localized vitiligo. J Pak Assoc Dermatol, 24(2) : 143-9.
Habib A,Raza N. .2012 .Clinical pattern of vitiligo. J Coll Physicians Surg Pak, 22(1) : 61-2.
Ibrahim ZA,Hassan GF,Elgendy HY,AlShenawy HA .2019 .Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo. J Cosmet Dermatol, 10(2) : 581-8.
Zandi S,Farajzadeh S,Saberi N. .2016 .Effect of vitiligo on self-reported quality of life in Southern part of Iran. J Pak Assoc Dermatol, 21(1) : 4-9.
Kumaran MS,Kaur I,Kumar B .2006 .Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol, 01420 : 3083-73.
Dogan AS,Atacan D,Durmazlar SPK,Acar M,Gurdal C .2015 .Evaluation of dry eye findings in patients with vitiligo. Pak J Med Sci, 10(3) : 587-91.
Al-Fahaad HA .2015 .Clinico-epidemiological profile of vitiligo patients in Najran Region, Saudi Arabia. J Dermatol Surg, 19(1) : 31-5.
0

Citations

0

Downloads

86

Views